Literature DB >> 27826473

Tissue Expander Infection in Breast Reconstruction: Importance of Nasopharynx Screening for Methicillin-resistant Staphylococcus aureus.

Akimitsu Nishibayashi1, Koichi Tomita1, Yuta Sugio1, Ko Hosokawa1, Kenji Yano1.   

Abstract

Entities:  

Year:  2016        PMID: 27826473      PMCID: PMC5096528          DOI: 10.1097/GOX.0000000000001076

Source DB:  PubMed          Journal:  Plast Reconstr Surg Glob Open        ISSN: 2169-7574


× No keyword cloud information.

Sir:

Postoperative infection is cited as a major complication of breast reconstruction using a tissue expander (TE). Once an infection develops, it is difficult to treat, often leading to TE evulsion and increased medical costs. Although there has been extensive research on TE infection risk factors, no studies have evaluated the relationship between the preoperative carrier status of patients and TE infection. This study investigated the correlation between postoperative TE infection and several factors, including preoperative carrier status, in 203 cases with TEs used in breast reconstructions performed between July 2013 and February 2016. This study was approved by the Ethics Committee of Osaka University, and informed written consent for publishing personal and medical information was obtained from all patients. All procedures conformed to the Declaration of Helsinki. All surgical procedures were performed by 2 plastic surgeons following identical protocols. Nasopharyngeal screening for carrier status was performed preoperatively on all patients, and the bacterial strain with the greatest volume and the patient’s methicillin-resistant Staphylococcus aureus (MRSA) carrier status were recorded. Excluding patients whose infections improved conservatively with only antibiotic treatment after drain removal, wound cultures or drainage cultures were performed on patients with an infection, and the phlogogenic bacterium was identified. We also selected the following risk factors: body mass index (kg/m2), method of breast cancer surgery (primary reconstruction only), history of axillary dissection (primary reconstruction only), timing of reconstruction, history of exposure to radiation, location of TE insertion, and amount of saline solution infused during surgery (evaluated based on the proportion of the total amount infused). Statistical analysis was performed using Statcel version 3 (OMS-publishing, Saitama, Japan). The data were analyzed using the chi-squared test. A value of P <0.05 was considered significant. Among the 203 TE cases, postoperative infection developed in 13 (6.4%). In 2 of these cases, the infection was alleviated with antibiotics. The remaining 11 patients required surgery: 9 were successfully treated and 2 underwent TE removal. The risk factor analysis suggested that obesity and preoperative presence of nasopharyngeal MRSA are significant risk factors for postoperative TE infection (Table 1). Additionally, axillary dissection tended to increase TE infection (P = 0.051). In 8 among 12 patients in whom the phlogogenic bacterium was identified, the same bacterium was found to show the greatest volume in the nasopharyngeal cultures (Table 2).
Table 1.

Factors Affecting Tissue Expander Infection

Table 2.

Phlogogenic Bacterium and Bacterial Flora in the Nasopharynx

Factors Affecting Tissue Expander Infection Phlogogenic Bacterium and Bacterial Flora in the Nasopharynx In addition to obesity, studies have also reported smoking, chemotherapy, large breast size, etc., as risk factors for postoperative breast prosthesis infection.[1, 2] The present study also investigated the relationship between nasopharyngeal carrier status and TE infection. The type of bacteria carried and the phlogogenic bacterium of TE infection were consistent in most patients, suggesting that preoperative nasopharyngeal screening could be effective. Additionally, 4 (33.3%) of the 12 patients who were MRSA carriers developed postoperative TE infections, 3 of whom had MRSA as a phlogogenic bacterium. Although first-generation cephem antibiotics are usually employed as perioperative antibiotics, in the future, research needs to be conducted on the effectiveness of preoperative MRSA eradication and perioperative use of anti-MRSA medications in MRSA carriers.[3-5]
  5 in total

1.  Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization.

Authors:  Andrew E Simor; Elizabeth Phillips; Allison McGeer; Ana Konvalinka; Mark Loeb; H Rosalyn Devlin; Alex Kiss
Journal:  Clin Infect Dis       Date:  2006-12-14       Impact factor: 9.079

2.  Breast tissue expander-related infections: perioperative antimicrobial regimens.

Authors:  George M Viola; Issam I Raad; Kenneth V Rolston
Journal:  Infect Control Hosp Epidemiol       Date:  2013-11-26       Impact factor: 3.254

3.  Independent risk factors for infection in tissue expander breast reconstruction.

Authors:  Stacey H Francis; Robert L Ruberg; Kurt B Stevenson; Catherine E Beck; Amy S Ruppert; Justin T Harper; James H Boehmler; Michael J Miller
Journal:  Plast Reconstr Surg       Date:  2009-12       Impact factor: 4.730

4.  Infection following implant-based reconstruction in 1952 consecutive breast reconstructions: salvage rates and predictors of success.

Authors:  Richard G Reish; Branimir Damjanovic; William G Austen; Jonathan Winograd; Eric C Liao; Curtis L Cetrulo; Daniel M Balkin; Amy S Colwell
Journal:  Plast Reconstr Surg       Date:  2013-06       Impact factor: 4.730

5.  Breast Implant-Associated Infections: The Role of the National Surgical Quality Improvement Program and the Local Microbiome.

Authors:  Justin B Cohen; Cathy Carroll; Marissa M Tenenbaum; Terence M Myckatyn
Journal:  Plast Reconstr Surg       Date:  2015-11       Impact factor: 4.730

  5 in total
  4 in total

1.  Surveillance and Prevention of Surgical Site Infections in Breast Oncologic Surgery with Immediate Reconstruction.

Authors:  Margaret A Olsen; Katelin B Nickel; Ida K Fox
Journal:  Curr Treat Options Infect Dis       Date:  2017-05-11

2.  Risk Factors for Complications in Expander-Based Breast Reconstruction: Multivariate Analysis in Asian Patients.

Authors:  Hirotaka Suga; Tomohiro Shiraishi; Naoko Tsuji; Akihiko Takushima
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-11-20

3.  Infectious Complications following Breast Reconstruction Using Tissue Expanders in Patients with Atopic Dermatitis.

Authors:  Mifue Taminato; Koichi Tomita; Kenji Yano; Ko Hosokawa
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-10-20

4.  Preventing infection after synthetic expander implantation in patients undergoing breast reconstruction.

Authors:  Satoko Onishi; Yoshikazu Inoue; Maki Inukai; Takayuki Okumoto
Journal:  Fujita Med J       Date:  2021-08-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.